PROSPECTUS

TERMS

By accessing this site you agree to and acknowledge that you have read and accept these terms and conditions of access.

An electronic form of the replacement Prospectus and application form dated 4 June 2015 (Prospectus) prepared by Medlab Clinical Limited (ACN 169 149 071) (Company) is available from this site.

The offer constituted by this prospectus in electronic form is available only to Australian residents accessing the website from Australia. A paper copy of the Prospectus is available free of charge to any person in Australia by calling 1300 369 570.

The Prospectus is an important document that should be read by prospective investors in its entirety before deciding whether to participate in the initial public offering of shares in the Company (Offer).

If after reading the Prospectus you have questions about the Offer, you should contact your stockbroker, accountant, financial, legal or other professional advisers.

By accessing the Prospectus (by clicking I Accept below) you acknowledge that you have read and accept the terms set out in this notice.


IMPORTANT NOTICE

The paper form of the electronic Prospectus accessible on this website is a replacement Prospectus dated 4 June 2015 (Prospectus) and was lodged with the Australian Securities and Investments Commission (ASIC) on that date.

The original prospectus dated 13 April 2015 was lodged with ASIC on that date. An application for the Company's Shares to be admitted to the Official List of the ASX was made on 13 April 2015.

The prospectus is a replacement prospectus which entirely replaces the supplementary prospectus dated 20 May 2015 and the replacement prospectus dated 20 April 2015 which entirely replaced the prospectus dated 13 April 2015.

Neither ASIC nor ASX Limited, nor any of their officers, take any responsibility for the contents of the Prospectus.

Anyone who wants to acquire shares in the Company will need to carefully consider the Prospectus and complete an application form that will be in, or will accompany, Prospectus. If you request a Prospectus you are not obliged to apply for shares.

The Company is not liable for any loss incurred from relying on this site, including from data corruption on download.

The information on this page is not part of the Prospectus.


Application for SHARES

Applicants for securities will be required to complete an Application Form that accompanies the Prospectus. The Corporations Act 2001 (Cth) prohibits any person from passing on to another person an application form unless it is attached to or accompanied by a complete and unaltered version of a prospectus.

The Company will not accept a completed Application Form if it has reason to believe that the Applicant has not received a complete and unaltered copy of the Prospectus. A paper copy of the Prospectus is available free of charge to any person in Australia by calling 1300 369 570.

Applications for Shares under the Offer must be made using the Prospectus Application Form attached to or accompanying the Prospectus.


Persons to whom offer is available

Due to legal restrictions, access to the Prospectus is restricted to persons accessing this website from within Australia. The Offers constituted by an electronic version of the Prospectus are only available to persons receiving an electronic version of the Prospectus within Australia.

The Prospectus does not constitute an offer or an invitation in any jurisdiction in which, or to any person to whom, it would not be lawful to make such an offer or invitation. The distribution of the Prospectus in jurisdictions outside Australia may be restricted by law and persons who come into possession of the Prospectus should seek advice on and observe any of these restrictions. Failure to comply with these restrictions may violate securities laws.

Applicants who are resident in countries other than Australia should consult their professional advisers as to whether any governmental or other consent are required or whether any other formalities need to be considered and followed.

Nothing in this website constitutes an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. The shares referred to herein have not been, and will not be, registered under the U.S. Securities Act of 1933 (U.S. Securities Act) or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold in the United States absent registration under the U.S. Securities Act or an exemption from registration requirements.


No advice included

Nothing contained on this website or in the Prospectus constitutes financial, investment, legal, business, tax or other advice. In particular, the information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of the Prospectus, including the merits and risks involved. You should consult your professional adviser for financial, legal, business or tax advice.


By clicking I Accept below you acknowledge that:

  • You have read and understood the above statements; and
  • You are an Australian resident and you are requesting a copy of the Prospectus from within Australia; or
  • If a non-Australian resident, you have consulted your professional adviser as to whether any governmental or other consents are required or whether any other formalities need to be considered and followed before accessing the Prospectus; and
  • You will not pass on to any other person the Application Form unless it is attached to or accompanied by the complete and unaltered electronic Prospectus.